COMMUNIQUÉS West-GlobeNewswire

Un médecin de famille pour chaque Canadienne et Canadien : Le CMFC exhorte les partis fédéraux à agir
01/04/2025
MISSISSAUGA, Ontario, 01 avr. 2025 (GLOBE NEWSWIRE) -- Le Collège des médecins de famille du Canada (CMFC) exhorte les partis politiques fédéraux à prendre des mesures visant à protéger et renforcer l’accès aux soins [...]
Fifty 1 Labs, Inc. Celebrates Groundbreaking SpaceX, NASA, and ISS Yeast Experiment by Subsidiary Genetic Networks
01/04/2025
Groundbreaking Yeast Experiment from Dr. Nislow's lab on Last Night's SpaceX Fram2 Mission Advances Space-Based Biotechnology MELBOURNE, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 Labs, Inc. ( Ticker: [...]
Stride Autism Centers Named a Winner of the 2025 Top Workplaces USA Today During Autism Acceptance Month
01/04/2025
Stride Expands Across the Midwest, Celebrating its Tenth Center in Iowa and Sixth in Nebraska DES MOINES, Iowa, April 01, 2025 (GLOBE NEWSWIRE) -- Stride Autism Centers, a leading provider of center-based early [...]
Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart
01/04/2025
– FDA aligned on plan to initiate parallel Phase 2 trials of rademikibart in patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation – – Expect to initiate both trials in Q2 2025 – SAN DIEGO, [...]
LogicMark Secures Approval to Deliver New Medical Alert with Cell Phone Tech to Veterans and Seniors Through U.S. General Services Administration
01/04/2025
The Freedom Alert Max brings life-saving fall detection, advanced geofencing capabilities, and patented 4G LTE mobile technology to vulnerable populations LOUISVILLE, Ky., April 01, 2025 (GLOBE NEWSWIRE) -- LogicMark, [...]
Capricor Therapeutics to Present at the 2025 Piper Sandler Virtual Cardio Day
01/04/2025
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today [...]
GRI Bio Reports Encouraging Interim 2-Week Safety Results from Ongoing Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”)
01/04/2025
The Independent Data Monitoring Committee (IDMC) has recommended to continue study as planned as there are no safety concerns seen in the data reviewed Interim results demonstrate GRI-0621 to be safe and well-tolerated [...]
ARTMS Drug Master File for Gallium Production Technology Referenced with Telix’s Gozellix®
01/04/2025
BURNABY, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Telix ARTMS, Inc. (ARTMS), a global leader in radioisotope production technologies, is pleased to announce that the drug master file (DMF) 1 for gallium-68 [...]
Updated biographies for board candidates at the upcoming Annual General Meeting
01/04/2025
1 April 2025 Announcement no. 8 Updated biographies for board candidates at the upcoming Annual General Meeting Copenhagen, Denmark, April 1, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an [...]
Cannabix Technologies to Attend U.S. National Drug and Alcohol Conference to Market Marijuana Breath Test
01/04/2025
VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing [...]
Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey
01/04/2025
Dr. Roman Kosiborod, DO to Utilize CompuFlo® for Enhanced Precision in Pain Management Procedures ROSELAND, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of [...]
REMINDER: Microbot Medical Announces Data from the Company’s ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting
01/04/2025
Company Reaffirms Expected Timing of FDA Decision With Respect to 510(K) Clearance of LIBERTY® During the Current Second Quarter BRAINTREE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT [...]
Moleculin Doses First Patient in Pivotal, Adaptive Phase 3 MIRACLE Trial
01/04/2025
– Initial data readout on track for second half of 2025 HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a [...]
Clene to Present at the Jones Healthcare and Technology Innovation Conference
01/04/2025
SALT LAKE CITY, April 01, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical [...]
Aptose Common Shares to Delist from Nasdaq as of April 2, 2025
01/04/2025
SAN DIEGO and TORONTO, April 01, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX:APS), a clinical-stage precision oncology company developing a tuspetinib (TUS) based [...]
Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson’s Disease at AD/PD 2025
01/04/2025
Solengepras showed evidence of potential benefit in functional and non-motor symptoms versus placebo as measured by MDS-UPRDS Parts I, II, NMSS, and ESS, consistent with its novel non-dopaminergic mechanism of action [...]
Unity Consortium Kicks Off Adolescent Immunization Action Week (AIAW25) to Help Parents and Adolescents Stay on TASK with Recommended Immunizations
01/04/2025
AIAW 2025 Runs April 7-11 to Encourage Well-Visits and Recommended Immunizations VENTNOR CITY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- UNITY® Consortium, a non-profit dedicated to adolescent and young adult [...]
Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment
01/04/2025
The clinical trial is designed to evaluate the safety, tolerability and efficacy of Clearmind’s innovative, psychedelic-derived, MEAI-based compound in individuals with alcohol addiction Vancouver, Canada, April 01, [...]
Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
01/04/2025
Lab network revenue increased by 33% year over year, reflecting strong demand for ColoAlert ® in Europe Operating loss decreased by 30% and net loss by 18%, driven by targeted cost reductions and a sharper strategic [...]

Pages